Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum YM BioSciences Inc YMI

Bullboard (NYSEAM:YMI)

View:
Comment by JuniorIOUon Aug 25, 2009 11:30am

RE: RE: Griffin Sec 5$US target

We could see $2.50 shortly.  Half way to the target price of $5.00 :)
Comment by JuniorIOUon Aug 25, 2009 11:05am

RE: Griffin Sec 5$US target

This is the part Like :)YMI SHARES REPRESENT EXCEPTIONAL VALUE. Given that the Company is trading near its cash balances of approximately $37 million as of March 31, 2009, nimotuzumab’s recent green ...more  
Post by greatemailslobon Aug 25, 2009 10:46am

Griffin Sec 5$US target

  ERBITUX® AND VECTIBIX® LIKELY TO BE SUPPLANTED BY YMI’S NIMOTUZUMAB AS THE EGFR MONOCLONAL ANTIBODY OF CHOICE IN A GREAT MAJORITY OF TUMORS. There has been a profound change in the ...more  
Comment by The_Shadowon Aug 17, 2009 11:32am

RE: RE: RE: RE: filled at 102 or less

So SLOB with your AEZ bombing today how long before your YM suffers the same fate???????????????????Welcome to the volatility of the BioTechs!!!LOL!!!!!!!!!!!!!!!
Post by redcoatson Aug 14, 2009 10:45am

Congrats

YM. Popped that $1.00 bubble. Next wall is Five.
Comment by greatemailslobon Aug 14, 2009 10:11am

RE: RE: RE: filled at 102 or less

thedave stop stalking me and buying my homersu think 10000 shares or 2000$ difference is going to make a difference if ym signs a US deal for p3 trialsthink 5 bucks and 20 cents is peanutsthink big or ...more  
Comment by thedave2006on Aug 14, 2009 7:03am

RE: RE: filled at 102 or less

why chase, 0.70s-0.80s a good spec if you like.dave.
Comment by greatemailslobon Aug 12, 2009 10:31am

RE: RE: RE: filled at 102 or less

turned around and bought in my long term account at 99 centscant not be invested
Comment by JuniorIOUon Aug 12, 2009 10:18am

RE: RE: filled at 102 or less

Heading thru $1.10 today? :)
Comment by greatemailslobon Aug 12, 2009 9:54am

RE: filled at 102 or less

no followthroughout at 97loss 239$oh boy!!!!!!!!!
Comment by The_Shadowon Aug 11, 2009 3:08pm

RE: filled at 102 or less

RE: RE: nice move through 1 buck  ...more  
Comment by thedave2006on Aug 10, 2009 8:07pm

RE: YM BioSciences shares soar on U.S. cancer tria

so will another pizzeria worker do the honors of recomending thi sone again.  lol.dave.
Post by 2ripon Aug 10, 2009 12:20pm

YM BioSciences shares soar on U.S. cancer trial ru

YM BioSciences shares soar on U.S. cancer trial ruling *U.S. ruling allows company to expand cancer trials *To ...more  
Comment by biovine811on Aug 10, 2009 10:14am

RE: News - WOW!!!

YM BIOSCIENCES USA RECEIVES CLEARANCE FROM US TREASURY DEPARTMENT So the big question is ---  Are the Americans allowed to buy this stock ???When did they know they were going to approve it and ...more  
Comment by greatemailslobon Aug 10, 2009 9:53am

RE: enormous upside

YM BioSciences (AMEX:YMI) (TSE:YM) (US$0.58) currently trades at a negative enterprise value of about $10 million (M), which includes $43M in cash, zero debt, and a trailing 12-month cash burn rate of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities